Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02216136 · ClinicalTrials.gov registry record
Tumor: Breast Ratio Study
A clinical trial, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- 162
- Enrollment target
NCT02216136: Completed study, sponsored by Washington University School of Medicine.
NCT02216136 is a clinical trial that has completed, run by Washington University School of Medicine. The registered enrollment target is 162 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02216136 has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- 162 participants
- Enrollment target
Study Summary
This is an observational study of 3 arms: breast conservation therapy, mastectomy and reconstruction, and mastectomy only.
Primary Outcome
The Breast Q is a comprehensive and specific quality of life instrument that allows for patient self-assessment prior to and following breast surgery. Comprised of quality of life and satisfaction domains, and generates domain-specific Q-scores (0-100) constructed using Rasch analysis. The higher the score, the more satisfied the participant was. -Collected preoperatively (no more than 3 months prior to surgery) and postoperatively (approximately 6 months after conclusion of radiotherapy in the
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 162 participants |
| Start Date | 2014-04-14 |
| Est. Completion | 2018-10-31 |
What the finished NCT02216136 record still lists
NCT02216136 is an observational study that tracks outcomes without assigning an intervention. The registered 162 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02216136 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02216136 about?
NCT02216136 is a clinical study titled "Tumor: Breast Ratio Study". This is an observational study of 3 arms: breast conservation therapy, mastectomy and reconstruction, and mastectomy only.
What is the current status of trial NCT02216136?
This trial is currently completed. The enrollment target is 162 participants. The study started on 2014-04-14. Estimated completion is 2018-10-31.
Who is sponsoring clinical trial NCT02216136?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02347111 · 162 participants · Phase 4
Pharmacogenetic Study of Antiarrhythmic Drugs for Atrial Fibrillation
- NCT02610426 · 162 participants
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Congestive Heart Failure Receiving Therapy for Breast Cancer
- NCT05040711 · 162 participants · NA
mHealth Mindfulness With Patients With Serious Illness and Their Caregivers
- NCT05514717 · 162 participants · Phase 1
A Study of XMT-2056 in Advanced/Recurrent Solid Tumors That Express HER2
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI